These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 16718892)

  • 1. Therapy for family, patient improves adherence. Intervention designed to reduce drug abuse relapse.
    AIDS Alert; 2006 May; 21(5):55-7. PubMed ID: 16718892
    [No Abstract]   [Full Text] [Related]  

  • 2. Optimizing treatment outcomes in HIV-infected patients with substance abuse issues.
    Celentano DD; Lucas G
    Clin Infect Dis; 2007 Dec; 45 Suppl 4():S318-23. PubMed ID: 18190306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavioral aspects of HIV care: adherence, depression, substance use, and HIV-transmission behaviors.
    Berg CJ; Michelson SE; Safren SA
    Infect Dis Clin North Am; 2007 Mar; 21(1):181-200, x. PubMed ID: 17502235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substance abuse treatment should be key component of HIV treatment plan. Experts explain some best-practice strategies.
    Agins B; Gourevitch M; Masci J; Rotheram-Borus MJ; Hitt RS; Haikalis S; Mabry SH; Gerse M
    AIDS Alert; 2001 Jul; 16(7):81-3. PubMed ID: 11548650
    [No Abstract]   [Full Text] [Related]  

  • 5. Prioritizing primary care in HIV: comorbidity, toxicity, and demography.
    Justice AC
    Top HIV Med; 2006 Dec-2007 Jan; 14(5):159-63. PubMed ID: 17237557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of ongoing illicit drug use on methadone adherence in illicit drug users receiving treatment for HIV in a directly observed therapy program.
    Raffa JD; Grebely J; Tossonian H; Wong T; Viljoen M; Khara M; Mead A; McLean M; Duncan F; Petkau AJ; DeVlaming S; Conway B
    Drug Alcohol Depend; 2007 Jul; 89(2-3):306-9. PubMed ID: 17383117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assess, refer, and treat: keys for substance abusers.
    Clements A; Gerse M; Gourevitch M; Havens J; Mabry SH; Masci J; Haikalis S; Rotheram-Borus MJ
    AIDS Alert; 2001 Jul; 16(7):83-6. PubMed ID: 11548651
    [No Abstract]   [Full Text] [Related]  

  • 8. Three year outcomes of an early intervention for psychosis service as compared with treatment as usual for first psychotic episodes in a standard community mental health team. Preliminary results.
    Agius M; Shah S; Ramkisson R; Murphy S; Zaman R
    Psychiatr Danub; 2007 Jun; 19(1-2):10-9. PubMed ID: 17603411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substance abuse in North Carolina.
    Silberman PC; Insko V; Nesbitt ML; Book D; Alexander-Bratcher K; Yorkery B; Hastings J; Shive D; Lichstein J; Holmes M
    N C Med J; 2009; 70(1):25-34. PubMed ID: 19534052
    [No Abstract]   [Full Text] [Related]  

  • 10. Economic evaluation of relapse prevention for substance users: treatment settings and health care policy.
    Yamada T; Chen CC; Yamada T
    Adv Health Econ Health Serv Res; 2005; 16():431-50. PubMed ID: 17867251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of drug abuse treatment modalities on adherence to ART/HAART among a cohort of HIV seropositive women.
    Kapadia F; Vlahov D; Wu Y; Cohen MH; Greenblatt RM; Howard AA; Cook JA; Goparaju L; Golub E; Richardson J; Wilson TE
    Am J Drug Alcohol Abuse; 2008; 34(2):161-70. PubMed ID: 18293232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Building a system to prevent addiction relapse.
    Levy M
    Behav Healthc Tomorrow; 2001 Dec; 10(6):34-7. PubMed ID: 11795229
    [No Abstract]   [Full Text] [Related]  

  • 13. Cost-effectiveness analysis of integrated care for people with HIV, chronic mental illness and substance abuse disorders.
    Weaver MR; Conover CJ; Proescholdbell RJ; Arno PS; Ang A; Uldall KK; Ettner SL
    J Ment Health Policy Econ; 2009 Mar; 12(1):33-46. PubMed ID: 19346565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of evidence-based psychosocial interventions for bipolar disorder.
    Miklowitz DJ
    J Clin Psychiatry; 2006; 67 Suppl 11():28-33. PubMed ID: 17029494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized clinical trial of community-based directly observed therapy as an adherence intervention for HAART among substance users.
    Macalino GE; Hogan JW; Mitty JA; Bazerman LB; Delong AK; Loewenthal H; Caliendo AM; Flanigan TP
    AIDS; 2007 Jul; 21(11):1473-7. PubMed ID: 17589194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infection following treatment of mandible fractures: the role of immunosuppression and polysubstance abuse.
    Senel FC; Jessen GS; Melo MD; Obeid G
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Jan; 103(1):38-42. PubMed ID: 17178492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adherence to HIV treatment among IDUs and the role of opioid substitution treatment (OST).
    Spire B; Lucas GM; Carrieri MP
    Int J Drug Policy; 2007 Aug; 18(4):262-70. PubMed ID: 17689374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Difficult-to-manage HIV/AIDS clients with psychiatric illness and substance abuse problems: a collaborative practice with psychiatric advanced practice nurses.
    Morgan BD; Rossi AP
    J Assoc Nurses AIDS Care; 2007; 18(6):77-84. PubMed ID: 17991601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An HIV-preventive intervention for youth living with HIV.
    Lightfoot M; Rotheram-Borus MJ; Tevendale H
    Behav Modif; 2007 May; 31(3):345-63. PubMed ID: 17438347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Family behavior therapy for substance abuse and other associated problems: a review of its intervention components and applicability.
    Donohue B; Azrin N; Allen DN; Romero V; Hill HH; Tracy K; Lapota H; Gorney S; Abdel-Al R; Caldas D; Herdzik K; Bradshaw K; Valdez R; Van Hasselt VB
    Behav Modif; 2009 Sep; 33(5):495-519. PubMed ID: 19592601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.